Sight Sciences Inc at Citi Healthcare & Medtech Conference Transcript
We're going again. I'm Joanne Wuensch. I'm a medical technology analyst here. And we have the management of Sight Sciences with us. So thank you all for joining us.
Thanks for having us, Joanne.
Questions & Answers
So I need to start big picture. And let's start with the MIGS market and the landscape. And how you see evolving, and maybe we'll call it, a post-pandemic environment?
Yeah. We're super excited about the market. There's the combo cataract segments that's growing nicely. We're continuing to take share in that segment. We're expanding the combo cataract segment in the market to advanced space. And then there's the much larger standalone opportunity, four to five times larger.
We're developing that market. We've got a unique indication for use, a unique usability and efficacy profile
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |